mRNAワクチンの世界市場（～2026年）

• 英文タイトル：Global mRNA Vaccine Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07910 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はmRNAワクチンのグローバル市場について調査・分析したレポートです。種類別（がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）市場規模、用途別（感染症、がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別mRNAワクチンの競争状況、市場シェア ・世界のmRNAワクチン市場：種類別市場規模 2015年-2020年（がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・世界のmRNAワクチン市場：種類別市場規模予測 2021年-2026年（がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・世界のmRNAワクチン市場：用途別市場規模 2015年-2020年（感染症、がん、その他） ・世界のmRNAワクチン市場：用途別市場規模予測 2021年-2026年（感染症、がん、その他） ・北米のmRNAワクチン市場分析：米国、カナダ ・ヨーロッパのmRNAワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのmRNAワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のmRNAワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのmRNAワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Market Analysis and Insights: Global mRNA Vaccine Market
The global mRNA Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global mRNA Vaccine Scope and Market Size
mRNA Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the mRNA Vaccine market is segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Segment by Application, the mRNA Vaccine market is segmented into
Infectious Disease
Cancer
Other

Regional and Country-level Analysis
The mRNA Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the mRNA Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and mRNA Vaccine Market Share Analysis
mRNA Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in mRNA Vaccine business, the date to enter into the mRNA Vaccine market, mRNA Vaccine product introduction, recent developments, etc.

The major vendors covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

レポート目次

---

1 Study Coverage
1.1 mRNA Vaccine Product Introduction
1.2 Market Segments
1.3 Key mRNA Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global mRNA Vaccine Market Size Growth Rate by Type
1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
1.4.3 Individualized Cancer Treatment MRNA Vaccine
1.4.4 Infectious Disease Treatment MRNA Vaccine
1.4.5 Infection Prevention MRNA Vaccine
1.5 Market by Application
1.5.1 Global mRNA Vaccine Market Size Growth Rate by Application
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global mRNA Vaccine Market Size, Estimates and Forecasts
2.1.1 Global mRNA Vaccine Revenue 2015-2026
2.1.2 Global mRNA Vaccine Sales 2015-2026
2.2 Global mRNA Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global mRNA Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global mRNA Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global mRNA Vaccine Competitor Landscape by Players
3.1 mRNA Vaccine Sales by Manufacturers
3.1.1 mRNA Vaccine Sales by Manufacturers (2015-2020)
3.1.2 mRNA Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 mRNA Vaccine Revenue by Manufacturers
3.2.1 mRNA Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by mRNA Vaccine Revenue in 2019
3.2.5 Global mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 mRNA Vaccine Price by Manufacturers
3.4 mRNA Vaccine Manufacturing Base Distribution, Product Types
3.4.1 mRNA Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers mRNA Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into mRNA Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global mRNA Vaccine Market Size by Type (2015-2020)
4.1.1 Global mRNA Vaccine Sales by Type (2015-2020)
4.1.2 Global mRNA Vaccine Revenue by Type (2015-2020)
4.1.3 mRNA Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global mRNA Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global mRNA Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global mRNA Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 mRNA Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global mRNA Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global mRNA Vaccine Market Size by Application (2015-2020)
5.1.1 Global mRNA Vaccine Sales by Application (2015-2020)
5.1.2 Global mRNA Vaccine Revenue by Application (2015-2020)
5.1.3 mRNA Vaccine Price by Application (2015-2020)
5.2 mRNA Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global mRNA Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global mRNA Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global mRNA Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America mRNA Vaccine by Country
6.1.1 North America mRNA Vaccine Sales by Country
6.1.2 North America mRNA Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America mRNA Vaccine Market Facts & Figures by Type
6.3 North America mRNA Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe mRNA Vaccine by Country
7.1.1 Europe mRNA Vaccine Sales by Country
7.1.2 Europe mRNA Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe mRNA Vaccine Market Facts & Figures by Type
7.3 Europe mRNA Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific mRNA Vaccine by Region
8.1.1 Asia Pacific mRNA Vaccine Sales by Region
8.1.2 Asia Pacific mRNA Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific mRNA Vaccine Market Facts & Figures by Type
8.3 Asia Pacific mRNA Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America mRNA Vaccine by Country
9.1.1 Latin America mRNA Vaccine Sales by Country
9.1.2 Latin America mRNA Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America mRNA Vaccine Market Facts & Figures by Type
9.3 Central & South America mRNA Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccine by Country
10.1.1 Middle East and Africa mRNA Vaccine Sales by Country
10.1.2 Middle East and Africa mRNA Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa mRNA Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa mRNA Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Description and Business Overview
11.1.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
11.1.5 Moderna Therapeutics Related Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Description and Business Overview
11.2.3 CureVac Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CureVac mRNA Vaccine Products Offered
11.2.5 CureVac Related Developments
11.3 Translate Bio
11.3.1 Translate Bio Corporation Information
11.3.2 Translate Bio Description and Business Overview
11.3.3 Translate Bio Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Translate Bio mRNA Vaccine Products Offered
11.3.5 Translate Bio Related Developments
11.4 BioNTech
11.4.1 BioNTech Corporation Information
11.4.2 BioNTech Description and Business Overview
11.4.3 BioNTech Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BioNTech mRNA Vaccine Products Offered
11.4.5 BioNTech Related Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Corporation Information
11.5.2 Sangamo Therapeutics Description and Business Overview
11.5.3 Sangamo Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sangamo Therapeutics mRNA Vaccine Products Offered
11.5.5 Sangamo Therapeutics Related Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Corporation Information
11.6.2 Argos Therapeutics Description and Business Overview
11.6.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Argos Therapeutics mRNA Vaccine Products Offered
11.6.5 Argos Therapeutics Related Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Corporation Information
11.7.2 In-Cell-Art Description and Business Overview
11.7.3 In-Cell-Art Sales, Revenue and Gross Margin (2015-2020)
11.7.4 In-Cell-Art mRNA Vaccine Products Offered
11.7.5 In-Cell-Art Related Developments
11.8 eTheRNA
11.8.1 eTheRNA Corporation Information
11.8.2 eTheRNA Description and Business Overview
11.8.3 eTheRNA Sales, Revenue and Gross Margin (2015-2020)
11.8.4 eTheRNA mRNA Vaccine Products Offered
11.8.5 eTheRNA Related Developments
11.9 Ethris
11.9.1 Ethris Corporation Information
11.9.2 Ethris Description and Business Overview
11.9.3 Ethris Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ethris mRNA Vaccine Products Offered
11.9.5 Ethris Related Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Corporation Information
11.10.2 Tiba Biotechnology Description and Business Overview
11.10.3 Tiba Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tiba Biotechnology mRNA Vaccine Products Offered
11.10.5 Tiba Biotechnology Related Developments
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Description and Business Overview
11.1.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
11.1.5 Moderna Therapeutics Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 mRNA Vaccine Market Estimates and Projections by Region
12.1.1 Global mRNA Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global mRNA Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America mRNA Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: mRNA Vaccine Sales Forecast (2021-2026)
12.2.2 North America: mRNA Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: mRNA Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe mRNA Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: mRNA Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: mRNA Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: mRNA Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific mRNA Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: mRNA Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: mRNA Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: mRNA Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America mRNA Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: mRNA Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: mRNA Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: mRNA Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa mRNA Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: mRNA Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: mRNA Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: mRNA Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key mRNA Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 mRNA Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. mRNA Vaccine Market Segments
Table 2. Ranking of Global Top mRNA Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global mRNA Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Table 5. Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Table 6. Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Table 7. Major Manufacturers of Infection Prevention MRNA Vaccine
Table 8. Global mRNA Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 9. Global mRNA Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 10. Global mRNA Vaccine Sales by Regions 2015-2020 (K Doses)
Table 11. Global mRNA Vaccine Sales Market Share by Regions (2015-2020)
Table 12. Global mRNA Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global mRNA Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 14. Global mRNA Vaccine Sales Share by Manufacturers (2015-2020)
Table 15. Global mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine as of 2019)
Table 17. mRNA Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. mRNA Vaccine Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers mRNA Vaccine Price (2015-2020) (USD/Dose)
Table 20. mRNA Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers mRNA Vaccine Product Type
Table 22. Date of International Manufacturers Enter into mRNA Vaccine Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 25. Global mRNA Vaccine Sales Share by Type (2015-2020)
Table 26. Global mRNA Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 27. Global mRNA Vaccine Revenue Share by Type (2015-2020)
Table 28. mRNA Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 29. Global mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 30. Global mRNA Vaccine Sales Share by Application (2015-2020)
Table 31. North America mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 32. North America mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 33. North America mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 34. North America mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 35. North America mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 36. North America mRNA Vaccine Sales Market Share by Type (2015-2020)
Table 37. North America mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 38. North America mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 39. Europe mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 40. Europe mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 41. Europe mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 43. Europe mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 44. Europe mRNA Vaccine Sales Market Share by Type (2015-2020)
Table 45. Europe mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 46. Europe mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific mRNA Vaccine Sales by Region (2015-2020) (K Doses)
Table 48. Asia Pacific mRNA Vaccine Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific mRNA Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific mRNA Vaccine Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 52. Asia Pacific mRNA Vaccine Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 54. Asia Pacific mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 55. Latin America mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 56. Latin America mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 59. Latin America mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 60. Latin America mRNA Vaccine Sales Market Share by Type (2015-2020)
Table 61. Latin America mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 62. Latin America mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa mRNA Vaccine Sales by Country (2015-2020) (K Doses)
Table 64. Middle East and Africa mRNA Vaccine Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa mRNA Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa mRNA Vaccine Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 68. Middle East and Africa mRNA Vaccine Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 70. Middle East and Africa mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 71. Moderna Therapeutics Corporation Information
Table 72. Moderna Therapeutics Description and Major Businesses
Table 73. Moderna Therapeutics mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 74. Moderna Therapeutics Product
Table 75. Moderna Therapeutics Recent Development
Table 76. CureVac Corporation Information
Table 77. CureVac Description and Major Businesses
Table 78. CureVac mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 79. CureVac Product
Table 80. CureVac Recent Development
Table 81. Translate Bio Corporation Information
Table 82. Translate Bio Description and Major Businesses
Table 83. Translate Bio mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 84. Translate Bio Product
Table 85. Translate Bio Recent Development
Table 86. BioNTech Corporation Information
Table 87. BioNTech Description and Major Businesses
Table 88. BioNTech mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 89. BioNTech Product
Table 90. BioNTech Recent Development
Table 91. Sangamo Therapeutics Corporation Information
Table 92. Sangamo Therapeutics Description and Major Businesses
Table 93. Sangamo Therapeutics mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 94. Sangamo Therapeutics Product
Table 95. Sangamo Therapeutics Recent Development
Table 96. Argos Therapeutics Corporation Information
Table 97. Argos Therapeutics Description and Major Businesses
Table 98. Argos Therapeutics mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 99. Argos Therapeutics Product
Table 100. Argos Therapeutics Recent Development
Table 101. In-Cell-Art Corporation Information
Table 102. In-Cell-Art Description and Major Businesses
Table 103. In-Cell-Art mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 104. In-Cell-Art Product
Table 105. In-Cell-Art Recent Development
Table 106. eTheRNA Corporation Information
Table 107. eTheRNA Description and Major Businesses
Table 108. eTheRNA mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 109. eTheRNA Product
Table 110. eTheRNA Recent Development
Table 111. Ethris Corporation Information
Table 112. Ethris Description and Major Businesses
Table 113. Ethris mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 114. Ethris Product
Table 115. Ethris Recent Development
Table 116. Tiba Biotechnology Corporation Information
Table 117. Tiba Biotechnology Description and Major Businesses
Table 118. Tiba Biotechnology mRNA Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 119. Tiba Biotechnology Product
Table 120. Tiba Biotechnology Recent Development
Table 121. Global mRNA Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 122. Global mRNA Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global mRNA Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global mRNA Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: mRNA Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 126. North America: mRNA Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: mRNA Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 128. Europe: mRNA Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: mRNA Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 130. Asia Pacific: mRNA Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: mRNA Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 132. Latin America: mRNA Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: mRNA Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 134. Middle East and Africa: mRNA Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key mRNA Vaccine Players
Table 139. mRNA Vaccine Customers List
Table 140. mRNA Vaccine Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccine Product Picture
Figure 2. Global mRNA Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Figure 4. Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Product Picture
Figure 6. Infection Prevention MRNA Vaccine Product Picture
Figure 7. Global mRNA Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. Infectious Disease
Figure 9. Cancer
Figure 10. Other
Figure 11. mRNA Vaccine Report Years Considered
Figure 12. Global mRNA Vaccine Market Size 2015-2026 (US$ Million)
Figure 13. Global mRNA Vaccine Sales 2015-2026 (K Doses)
Figure 14. Global mRNA Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global mRNA Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global mRNA Vaccine Sales Market Share by Region in 2019
Figure 17. Global mRNA Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global mRNA Vaccine Revenue Market Share by Region in 2019
Figure 19. Global mRNA Vaccine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by mRNA Vaccine Revenue in 2019
Figure 21. mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global mRNA Vaccine Sales Market Share by Type (2015-2020)
Figure 23. Global mRNA Vaccine Sales Market Share by Type in 2019
Figure 24. Global mRNA Vaccine Revenue Market Share by Type (2015-2020)
Figure 25. Global mRNA Vaccine Revenue Market Share by Type in 2019
Figure 26. Global mRNA Vaccine Market Share by Price Range (2015-2020)
Figure 27. Global mRNA Vaccine Sales Market Share by Application (2015-2020)
Figure 28. Global mRNA Vaccine Sales Market Share by Application in 2019
Figure 29. Global mRNA Vaccine Revenue Market Share by Application (2015-2020)
Figure 30. Global mRNA Vaccine Revenue Market Share by Application in 2019
Figure 31. North America mRNA Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 32. North America mRNA Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America mRNA Vaccine Sales Market Share by Country in 2019
Figure 34. North America mRNA Vaccine Revenue Market Share by Country in 2019
Figure 35. U.S. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 36. U.S. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Canada mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America mRNA Vaccine Market Share by Type in 2019
Figure 40. North America mRNA Vaccine Market Share by Application in 2019
Figure 41. Europe mRNA Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 42. Europe mRNA Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe mRNA Vaccine Sales Market Share by Country in 2019
Figure 44. Europe mRNA Vaccine Revenue Market Share by Country in 2019
Figure 45. Germany mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Germany mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 48. France mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. U.K. mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Italy mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Russia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe mRNA Vaccine Market Share by Type in 2019
Figure 56. Europe mRNA Vaccine Market Share by Application in 2019
Figure 57. Asia Pacific mRNA Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 58. Asia Pacific mRNA Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific mRNA Vaccine Sales Market Share by Region in 2019
Figure 60. Asia Pacific mRNA Vaccine Revenue Market Share by Region in 2019
Figure 61. China mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 62. China mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 64. Japan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. South Korea mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. India mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Australia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Taiwan mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Indonesia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Thailand mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Malaysia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 80. Philippines mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 82. Vietnam mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific mRNA Vaccine Market Share by Type in 2019
Figure 84. Asia Pacific mRNA Vaccine Market Share by Application in 2019
Figure 85. Latin America mRNA Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 86. Latin America mRNA Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America mRNA Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America mRNA Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 90. Mexico mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 92. Brazil mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 94. Argentina mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America mRNA Vaccine Market Share by Type in 2019
Figure 96. Latin America mRNA Vaccine Market Share by Application in 2019
Figure 97. Middle East and Africa mRNA Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 98. Middle East and Africa mRNA Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa mRNA Vaccine Sales Market Share by Country in 2019
Figure 100. Middle East and Africa mRNA Vaccine Revenue Market Share by Country in 2019
Figure 101. Turkey mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 102. Turkey mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 104. Saudi Arabia mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E mRNA Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 106. U.A.E mRNA Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa mRNA Vaccine Market Share by Type in 2019
Figure 108. Middle East and Africa mRNA Vaccine Market Share by Application in 2019
Figure 109. North America mRNA Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 110. North America mRNA Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe mRNA Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 112. Europe mRNA Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific mRNA Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 114. Asia Pacific mRNA Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America mRNA Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. Latin America mRNA Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa mRNA Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Middle East and Africa mRNA Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

---